Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
CN |
|
B
|
Best Buy Co Inc
BMV:BBY
|
US |
|
ABB India Ltd
NSE:ABB
|
IN |
|
I
|
iQIYI Inc
SWB:IQ8
|
CN |
|
China Vanke Co Ltd
F:18V0
|
CN |
|
Tarsons Products Ltd
NSE:TARSONS
|
IN |
|
Renewi PLC
F:1K5A
|
UK |
|
G
|
Global Health Clinics Ltd
F:L00
|
CA |
|
Raytheon Technologies Corp
NYSE:RTX
|
US |
|
C
|
Coheris SA
XBER:OHE
|
FR |
|
Fine Organic Industries Ltd
NSE:FINEORG
|
IN |
|
Allbirds Inc
NASDAQ:BIRD
|
US |
Wall St Price Targets
Price Targets Summary
Jiangsu Hengrui Pharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for Jiangsu Hengrui Pharmaceuticals Co Ltd is 82.53 CNY with a low forecast of 70.2 CNY and a high forecast of 129.15 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's stock price target?
Price Target
82.53
CNY
According to Wall Street analysts, the average 1-year price target for Jiangsu Hengrui Pharmaceuticals Co Ltd is 82.53 CNY with a low forecast of 70.2 CNY and a high forecast of 129.15 CNY.
What is the Revenue forecast for Jiangsu Hengrui Pharmaceuticals Co Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for Jiangsu Hengrui Pharmaceuticals Co Ltd?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Jiangsu Hengrui Pharmaceuticals Co Ltd?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 8 years is 26%.
What is the Pre-Tax Income forecast for Jiangsu Hengrui Pharmaceuticals Co Ltd?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 22%.
What is the Net Income forecast for Jiangsu Hengrui Pharmaceuticals Co Ltd?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 3 years is 21%.
